glp-1 cardiovascular outcomes news Impact of receptor agonists on in heart failure with preserved ejection fraction (HFpEF): systematic review and meta-analysis | Clinical Research in Cardiology Beyond GLP1: modulating multiple nutrient-stimulated
Description
F1000Research , 3 , 157
Advances in Nutrition
Add a hard-boiled egg if you need more protein
The study of the PIONEER and SUSTAIN trials found people who took semaglutide drugs had a 3.66 times higher risk of DVT
Cardiovasc Diabetol 17(1):132 Santos-Gallego CG, Requena-Ibanez JA, San Antonio R, Ishikawa K, Watanabe S, Picatoste B, Flores E, Garcia-Ropero A, Sanz J, Hajjar RJ, Fuster V, Badimon JJ
Semaglutide sold as Wegovy is currently the most commonly prescribed GLP-1 medication for managing obesity
